Effective weight loss after treatment with a glucagon-like peptide-1 receptor agonist in a morbidly obese and diabetic patient before bariatric surgery: a case report

INTRODUCTION: Glucagon-like peptide-1 receptor agonists, a new class of anti-diabetic drugs, are widely used in the treatment of type 2 diabetes. However, the effect of glucagon-like peptide-1 receptor agonists on the treatment of preoperative weight loss in obese type 2 diabetic patients has not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jui-Hung, Tang, Wen-Hao, Lee, Chien-Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164326/
https://www.ncbi.nlm.nih.gov/pubmed/25213589
http://dx.doi.org/10.1186/1752-1947-8-304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164326/
https://www.ncbi.nlm.nih.gov/pubmed/25213589
http://dx.doi.org/10.1186/1752-1947-8-304

Ejemplares similares